Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Chelsey Campbell, PharmD, MBA
Assistant Director
Xcenda
Palm Harbor, FL
Assistant Director, Global Health Economics and Outcomes Research, Xcenda, Palm Harbor, FL
Authored Items
Treatment Patterns and Outcomes in Patients with Varicose Veins
Rajiv Mallick, PhD
,
Aditya Raju, MS, BPharm
,
Chelsey Campbell, PharmD, MBA
,
Rashad Carlton, PharmD, MSPH
,
David Wright, MD
,
Kimberly Boswell, MD
,
Michael Eaddy, PharmD, PhD
,
Gary M. Owens, MD
November 2016 Vol 9, No 8
in
Clinical
Evaluating Outcomes in Patients with Overactive Bladder within an Integrated Healthcare Delivery System Using a Treatment Patterns Analyzer
Kelly Huang, PhD
,
Daniel B. Ng, PharmD, MBA
,
Melissa McCart, PharmD, MS
,
Christopher Klein, BS
,
Chelsey Campbell, PharmD, MBA
,
Robert Schoenhaus, PharmD
,
Todd Berner, MD
September 2016 Vol 9, No 6
in
Clinical
Evaluating the Expected Costs and Budget Impact of Interventional Therapies for the Treatment of Chronic Venous Disease
Rashad Carlton, PharmD, MSPH
,
Rajiv Mallick, PhD
,
Chelsey Campbell, PharmD, MBA
,
Aditya Raju, MS, BPharm
,
Thomas O'Donnell, MD
,
Michael Eaddy, PharmD, PhD
,
Michael F. Murphy, MD, PhD
,
Michael Eaddy, PharmD, PhD
,
Michael F. Murphy, MD, PhD
October 2015 Vol 8, No 7
in
Business
,
Original Research
Last modified: November 16, 2016